KRISTINA SCHAEFER: Open Payments
NPI 1649542846 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 12 payments from 8 companies in 2025. Trend: 2023 $579 · 2024 $1,101 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $108 |
| E.R. Squibb & Sons, L.L.C. | 2 | $58 |
| Neurocrine BioSciences, Inc. | 1 | $34 |
| Lundbeck LLC | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Alkermes, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, COBENFY, REXULTI, INGREZZA, UZEDY, LYBALVI, Qelbree.
Industry payments across WI — which companies pay providers there.
